Sign Up to like & get
recommendations!
1
Published in 2022 at "Cell Death Discovery"
DOI: 10.1038/s41420-021-00801-9
Abstract: Sodium-glucose cotransporter 2 inhibitors, which are recently introduced as glucose-lowering agents, improve cardiovascular and renal outcomes in patients with diabetes mellitus. These drugs also have beneficial effects in various kidney disease models. However, the effect…
read more here.
Keywords:
canagliflozin protects;
canagliflozin;
protects cisplatin;
renal proximal ... See more keywords